Michael Ehlers
Michael Ehlers | |
|---|---|
| Born | |
| Nationality | American |
| Alma mater | Caltech, Johns Hopkins University |
| Known for | neurotransmitter receptors |
| Scientific career | |
| Fields | Neuroscience |
| Institutions | Biogen |
| Doctoral advisor | Richard L. Huganir |
Michael D. Ehlers is the Executive Vice President for Research and Development at Biogen. He was formerly the Chief Scientific Officer for Neuroscience at Pfizer. Prior to joining industry, Ehler was the George Barth Geller Professor of Neurobiology and a Howard Hughes Medical Institute investigator at the Duke University Medical Center. His academic work was focused around neuronal organelles and the trafficking of neurotransmitter receptors.[1]
He has a BS in chemistry from Caltech in 1991 and an MD and a PhD in neuroscience at Johns Hopkins School of Medicine with Richard L. Huganir.[2] His work at Duke was centered around the trafficking of neurotransmitter receptors notably the AMPA receptor.[3][4]
Ehler was born in Germany and raised in rural Nebraska. He plays French horn and piano. He first became interested in science as a child collecting insects and rocks. He was introduced to neurobiology when his girlfriend now wife suggested that math was involved with the field.[5]
References
- ^ "Michael Ehlers". Neuron. 91 (1): 15–18. July 2016. doi:10.1016/j.neuron.2016.06.024.
- ^ "Angelman Syndrome Foundation". www.angelman.org. Retrieved 12 March 2018.
- ^ Ehlers, Michael D (November 2000). "Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting". Neuron. 28 (2): 511–525. doi:10.1016/S0896-6273(00)00129-X. PMID 11144360.
- ^ Park, M. (24 September 2004). "Recycling Endosomes Supply AMPA Receptors for LTP". Science. 305 (5692): 1972–1975. doi:10.1126/science.1102026. PMID 15448273.
- ^ "Interview with Michael D. Ehlers". Trends in Neurosciences. 35 (5): 271–273. May 2012. doi:10.1016/j.tins.2011.12.008.